Exploring Synergy in Combinations of Tumor-Derived Vaccines That Harbor 4-1BBL, OX40L, and GM-CSF

Por Andrea J. Manrique-Rincón, Andrea J. Manrique-Rincón, Camila M. Beraldo, Jessica M. Toscaro, Marcio C. Bajgelman, Marcio C. Bajgelman, Marcio C. Bajgelman
Publicado em 2017-09-01